Description

Modern Diagnostic & Research Centre Limited equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.

Summary

BSE has announced that the equity shares of Modern Diagnostic & Research Centre Limited (Scrip Code: 544673), currently listed in the SME segment, will be transferred from the Trade for Trade segment (MT Group) to the Rolling settlement segment (M Group) effective January 21, 2026. This change follows a previous notice dated January 6, 2026.

Key Points

  • Company: Modern Diagnostic & Research Centre Limited (SME IPO)
  • Scrip Code: 544673
  • Current Classification: Trade for Trade segment (MT Group)
  • New Classification: Rolling segment (M Group)
  • Effective Date: January 21, 2026
  • Segment: SME
  • Notice Reference: Continuation of Notice No. 20260106-16 dated January 6, 2026
  • Contact Person: Mr. Anurag Jain (Tel: 022-2272 8822)

Regulatory Changes

The trading mechanism for Modern Diagnostic & Research Centre Limited will change from Trade for Trade (T2T) basis to Rolling settlement. This transition indicates:

  • Removal from MT Group (Trade for Trade segment with special surveillance)
  • Inclusion in M Group (normal Rolling settlement segment)
  • Enhanced liquidity as shares can be traded on normal settlement basis rather than compulsory delivery
  • Reduced surveillance measures on the stock

Compliance Requirements

Trading members should:

  • Update their systems to reflect the group change from MT to M Group
  • Inform clients trading in this scrip about the change in trading mechanism
  • Ensure proper settlement procedures are followed post-transition
  • Contact Mr. Anurag Jain at BSE for any clarifications (Tel: 022-2272 8822)

Important Dates

  • January 6, 2026: Previous notice issued (Notice No. 20260106-16)
  • January 7, 2026: Current notice date
  • January 21, 2026: Effective date for transfer from MT Group to M Group

Impact Assessment

Positive Impact:

  • Improved liquidity for shareholders as the stock moves from restrictive Trade for Trade to normal Rolling settlement
  • Increased market participation expected due to removal of compulsory delivery requirement
  • Indicates compliance with BSE requirements and reduced surveillance concerns
  • Potential for better price discovery through increased trading activity

Operational Impact:

  • Trading members need to update systems and inform clients
  • Settlement cycle changes from T2T to normal T+1 rolling settlement
  • Brokers may see increased trading volumes in this scrip

Market Significance: The move from MT Group to M Group is generally viewed positively as it signals that the stock has met BSE’s criteria for normal trading, reducing restrictions that were previously in place.

Impact Justification

Segment change affects trading mechanism for this SME IPO stock, moving from restrictive Trade for Trade to normal Rolling settlement, indicating improved liquidity and reduced surveillance measures.